Latest filing published 03 Mar 2023 for 康弘药业, €55k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -2.3%Entry CN¥18.02 · Close at T+365 CN¥17.60
- -32.7%Entry CN¥21.12 · Close at T+365 CN¥14.22
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
柯潇: trading record in brief
柯潇 (board member) discloses dealings in 康弘药业 to SSE / SZSE (CSRC). In total, 2 filings cover trades dated from 19 May 2021 to 3 March 2023.
On the market, this insider has only ever bought: 2 purchases, €2.8M in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2023 alone, the filings show 1 purchase and no sales.
On 3 March 2023 came the latest disclosure, an open-market purchase for €55k in 康弘药业. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Companies and markets linked to 柯潇
Open company profiles for insider transactions, fundamentals and analyst consensus when available.